Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice.
about
Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice.Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases.Cognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models?Pituitary adenylate cyclase activating polypeptide modulates catecholamine storage and exocytosis in PC12 cells.A mouse model of L-2-hydroxyglutaric aciduria, a disorder of metabolite repair.Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signalingPituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells.PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2.Acute exposure to zinc oxide nanoparticles does not affect the cognitive capacity and neurotransmitters levels in adult rats.Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis.Lack of long-term changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse models of Parkinson's disease.Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys.Indomethacin promotes survival of new neurons in the adult murine hippocampus accompanied by anti-inflammatory effects following MPTP-induced dopamine depletion.Aluminium oxide nanoparticles compromise spatial learning and memory performance in rats.
P2860
Q30475706-8EA32BD1-D3C3-4D4D-ACE3-D399C5750534Q34179881-D928EA8B-B773-4322-955A-4B4E0C35C460Q34307633-9559C37C-25DC-437E-BBD2-3CD385AF8D53Q35113313-D690F05F-71B3-41A8-9363-F995D455BE2EQ35170886-0E869B32-5493-4B69-AC7B-8BFCF4DA5152Q35858131-2F40A95D-31F7-4E2E-94CB-9B66311C44B5Q39678162-42EFE0B3-7D37-4CFB-97FC-D5D5BB5CF497Q41769727-1900839E-99B0-498F-9FEE-7CF46233B39CQ42643098-8C5520E3-F8ED-4480-86CB-FF49EC2AAEF5Q45817009-364B804B-9572-4ED8-B00C-AE7395995D39Q46112535-E419807D-2A08-496E-9103-1A2BA4D07E7CQ47303830-D9CA9729-6952-488B-9C7C-E0A062810334Q55216971-C76591D9-982E-4D5A-81C7-7D1607709969Q55340905-4242D832-F3F3-46AA-B089-A19C9D24DDF6
P2860
Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Neuroprotective effect of PACA ...... ine in MPTP parkinsonian mice.
@en
Neuroprotective effect of PACA ...... ine in MPTP parkinsonian mice.
@nl
type
label
Neuroprotective effect of PACA ...... ine in MPTP parkinsonian mice.
@en
Neuroprotective effect of PACA ...... ine in MPTP parkinsonian mice.
@nl
prefLabel
Neuroprotective effect of PACA ...... ine in MPTP parkinsonian mice.
@en
Neuroprotective effect of PACA ...... ine in MPTP parkinsonian mice.
@nl
P2093
P1476
Neuroprotective effect of PACA ...... ine in MPTP parkinsonian mice.
@en
P2093
Bernard Fauconneau
Claire Lafay-Chebassier
François Chavant
Julie Deguil
Marie-Christine Pérault-Pochat
Stéphanie Pain
P2860
P2888
P304
P356
10.1007/S12640-009-9091-4
P577
2009-07-21T00:00:00Z
P5875
P6179
1022114312